Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2637 USD | -1.42% | +5.44% | -38.69% |
May. 23 | Theriva Biologics Gets Fast Track Designation for Pancreatic Cancer Treatment | MT |
May. 23 | Theriva Biologics, Inc Announces U.S. Food and Drug Administration Granted Fast Track Designation | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.56M |
---|---|---|---|---|---|
Net income 2024 * | -28M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.33
x | P/E ratio 2025 * |
-0.35
x | Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.16% |
Latest transcript on Theriva Biologics, Inc.
1 day | -1.42% | ||
1 week | +5.44% | ||
Current month | +5.44% | ||
1 month | -37.06% | ||
3 months | -43.89% | ||
6 months | -52.05% | ||
Current year | -38.69% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 15-05-31 | |
Michael Kaleko
CTO | Chief Tech/Sci/R&D Officer | - | 12-02-29 |
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Wolf
BRD | Director/Board Member | 60 | 05-12-31 |
John Monahan
BRD | Director/Board Member | 77 | 20-11-10 |
Jeffrey Kraws
CHM | Chairman | 59 | 05-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 0.2637 | -1.42% | 353,338 |
24-06-06 | 0.2675 | -4.12% | 265,761 |
24-06-05 | 0.279 | +9.84% | 304,186 |
24-06-04 | 0.254 | -3.42% | 429,433 |
24-06-03 | 0.263 | +5.16% | 363,834 |
Delayed Quote Nyse, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.69% | 4.56M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- TOVX Stock